Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: Medical Equipment/Supplies/Accessories | | Sceptre Medical (I) Share Price
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: Medical Equipment/Supplies/Accessories | | Sceptre Medical (I) Share Price
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
| PARTICULARS | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|
| Sales | 22.24 | 28.69 | 67.95 |
| Operating Expenses ⓘ + | 18.65 | 22.47 | 51.41 |
| Operating Profit ⓘ | 3.59 | 6.23 | 16.54 |
| Operating Profit Margin (%) | 16.1% | 21.7% | 24.3% |
| Other Income ⓘ + | 0.18 | 0.06 | 0.51 |
| Interest ⓘ | 0.65 | 0.65 | 1.41 |
| Depreciation ⓘ | 0.68 | 0.70 | 1.08 |
| Profit Before Tax ⓘ | 2.44 | 4.99 | 14.94 |
| Tax ⓘ | 0.74 | 0.88 | 3.46 |
| Profit After Tax | 1.70 | 4.11 | 11.49 |
| PAT Margin (%) | 7.7% | 14.3% | 16.9% |
| Adjusted EPS (₹) | 1.1 | 2.7 | 6.4 |
| Dividend Payout Ratio (%) | 0% | 0% | 0% |
| PARTICULARS | Mar'24 | Mar'25 | Mar'26 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 9.15 | 13.15 | 29.91 | ||||||||
| Debt + | 6.34 | 6.39 | 29.62 | ||||||||
| Minority Interest | 0 | 0 | 2.04 | ||||||||
| Trade Payables | 0.93 | 2.33 | 4.93 | ||||||||
| Others Liabilities ⓘ | 4.45 | 5.54 | 12.17 | ||||||||
| Total Liabilities ⓘ | 20.86 | 27.41 | 78.68 | ||||||||
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 7.96 | 12.89 | 18.81 | ||||||||
| CWIP ⓘ | 0 | 0 | 4.75 | ||||||||
| Investments ⓘ | 2.97 | 0.87 | 0 | ||||||||
| Inventories | 4.14 | 7.12 | 12.49 | ||||||||
| Trade Receivables | 4.71 | 5.24 | 30.21 | ||||||||
| Cash Equivalents | 0.48 | 0.24 | 5.02 | ||||||||
| Others Assets ⓘ | 0.61 | 1.05 | 7.40 | ||||||||
| Total Assets ⓘ | 20.86 | 27.41 | 78.68 | ||||||||
| PARTICULARS | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 0 | 4.16 | -1.93 |
| Cash Flow From Investing Activity ⓘ + | 0 | -4.13 | -12.24 |
| Cash Flow From Financing Activity ⓘ + | 0 | -0.27 | 18.77 |
| Net Cash Flow ⓘ | 0 | -0.24 | 4.60 |
| PARTICULARS | Mar'24 | Mar'25 | Mar'26 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 18.61 | 36.85 | 53.35 | |||||||
| ROCE (%) | 17.74 | 28.73 | 38.66 | |||||||
| Asset Turnover Ratio | 1.07 | 1.19 | 1.28 | |||||||
| PAT to CFO Conversion(x) | 0 | 1.01 | -0.17 | |||||||
| Working Capital Days | ||||||||||
| Receivable Days | 77.40 | 63.30 | 95.20 | |||||||
| Inventory Days | 67.90 | 71.60 | 52.70 | |||||||
| Payable Days | 26.20 | 35.80 | 34.30 | |||||||

